Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT03875508

Public ClinicalTrials.gov record NCT03875508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Plaque Psoriasis: Usability of the Risankizumab Autoinjector Combination Product in Adults With Moderate to Severe Psoriasis

Study identification

NCT ID
NCT03875508
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
108 participants

Conditions and interventions

Conditions

Interventions

  • Autoinjector Device
  • Risankizumab Drug

Device · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 3, 2019
Primary completion
Apr 23, 2020
Completion
Aug 24, 2020
Last update posted
May 10, 2021

2019 – 2020

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Advanced Research Associates /ID# 210634 Glendale Arizona 85308
Cognitive Clinical Trials /ID# 210770 Scottsdale Arizona 85258-4446
Burke Pharmaceutical Research /ID# 211386 Hot Springs Arkansas 71913-6404
Bakersfield Derma & Skin Cance /ID# 210773 Bakersfield California 93309
Encino Research Center / T. Jo /ID# 211735 Encino California 91436
Tien Q Nguyen MD, Inc /ID# 210775 Fountain Valley California 92708-3701
UC Davis Health /ID# 210411 Sacramento California 95816
Dermatology Physicians of CT /ID# 210637 Shelton Connecticut 06484-6211
Florida Academic Centers Research /ID# 210337 Coral Gables Florida 33134
Medallion Clinical Research Institute, LLC /ID# 210329 Naples Florida 34102
Renstar Medical Research /ID# 210878 Ocala Florida 34470
Epiphany Dermatology /ID# 211493 Overland Park Kansas 66215
DermAssociates /ID# 210838 Rockville Maryland 20850
Great Lakes Research, Inc. /ID# 210192 Bay City Michigan 48602
Somerset Skin Centre /ID# 211596 Troy Michigan 48084
Central Dermatology, PC /ID# 210301 St Louis Missouri 63117
AllCutis Research Inc /ID# 211429 Portsmouth New Hampshire 03801
Medication Management, LLC /ID# 213217 Greensboro North Carolina 27408
Oregon Medical Res Center PC /ID# 210334 Portland Oregon 97223
University of Pittsburgh MC /ID# 210839 Pittsburgh Pennsylvania 15260
Center for Clinical Studies /ID# 211565 Cypress Texas 77433
Center for Clinical Studies /ID# 210362 Houston Texas 77004
Suzanne Bruce and Associates /ID# 212210 Houston Texas 77056
Austin Institute for Clinical Research /ID# 212203 Pflugerville Texas 78660
Premier Clinical Research /ID# 212209 Spokane Washington 99202
Froedtert Mem Lutheran Hosp /ID# 210194 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03875508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2021 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03875508 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →